subject: CHEBI:28901

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:28901

subject_name: Busulfan

object_name: recurrent extragonadal germ cell tumor

tested_intervention: unsure


subject: CHEBI:28901

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:28901

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:28901

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:28901

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:28901

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:28901

object_name: recurrent extragonadal non-seminomatous germ cell tumor


subject: CHEBI:28901

object_name: adult central nervous system germ cell tumor


subject: CHEBI:28901

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:28901

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:28901

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:28901

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:28901

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:28901

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:28901

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:28901

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:28901

object_name: previously untreated childhood rhabdomyosarcoma


subject: CHEBI:28901

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:PVI5M0M1GW

object_name: recurrent extragonadal germ cell tumor


subject: UNII:PVI5M0M1GW

object_name: Recurrent Kidney Wilms Tumor


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Recurrent tumors of the Ewing's family


subject: UNII:PVI5M0M1GW

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932

object_name: recurrent extragonadal non-seminomatous germ cell tumor


subject: PR:000005932

object_name: adult central nervous system germ cell tumor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:82339

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:82339

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:82339

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:82339

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:82339

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:82339

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:82339

object_name: previously untreated childhood rhabdomyosarcoma


subject: CHEBI:82339

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:28876

object_name: recurrent extragonadal germ cell tumor


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876

object_name: recurrent extragonadal non-seminomatous germ cell tumor


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632

object_name: Testis cancer recurrent


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632

object_name: adult central nervous system germ cell tumor


subject: CHEBI:63632


subject: CHEBI:63632

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:63632

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UMLS:C5222001

subject_name: whey protein hydrolysate

object_name: type 2 diabetes mellitus

tested_intervention: yes


subject: UMLS:C5222001

object_name: Diabetes


subject: UMLS:C5222001

object_name: diabetes mellitus


subject: UMLS:C5222001

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5222001

object_name: obesity


subject: UMLS:C5222001

object_name: Obesity, CTCAE


subject: CHEBI:35476

subject_name: antipsychotic agent

object_name: mental disorder


subject: CHEBI:35476

object_name: psychiatric disorder


subject: UMLS:C0040615

subject_name: Antipsychotic Agents


subject: UMLS:C0040615


subject: CHEBI:35469

subject_name: antidepressant


subject: CHEBI:35469


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: UMLS:C4020582

subject_name: Mood Stabilizers


subject: UMLS:C4020582


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: cardiovascular disorder


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: UMLS:C0937831

subject_name: poppy extract


subject: UMLS:C1254351

subject_name: Pharmacologic Substance

object_name: fibromyalgia


subject: CHEBI:32599


subject: CHEBI:3223

subject_name: Buspirone

object_name: opiate dependence


subject: CHEBI:3223

object_name: Opioid withdrawal


subject: CHEBI:8871

subject_name: Risperidone


subject: UMLS:C5667085

subject_name: Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218

object_name: ovarian cancer


subject: UMLS:C5667085

object_name: ovarian neoplasm


subject: UMLS:C5667085

object_name: ovarian carcinoma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Coronavinae infectious disease


subject: UNII:UG7I3Y42PV

subject_name: Fluoroazomycin arabinoside F-18

object_name: skull base chordoma


subject: UNII:UG7I3Y42PV

object_name: spinal chordoma


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Hoarding Disorder


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: hepatitis B


subject: CHEBI:144903

object_name: diphtheria


subject: CHEBI:144903

object_name: tetanus


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:68534

object_name: Metastatic malignant neoplasm to soft tissues


subject: DRUGBANK:DB14239

subject_name: Echinacea purpurea

object_name: Upper Respiratory Infections


subject: DRUGBANK:DB14239

object_name: respiratory tract infectious disorder


subject: DRUGBANK:DB14239

object_name: Recurrent upper respiratory tract infections


subject: DRUGBANK:DB06069

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB06069

object_name: small cell lung carcinoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: Fetal anomaly


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: colorectal neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Reperfusion Injury


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: anterior ischemic optic neuropathy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: HIV infection


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:174428


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: PUBCHEM.COMPOUND:23724878

object_name: staphylococcal infection


subject: PUBCHEM.COMPOUND:23724878

object_name: Staphylococcal Skin Infections


subject: CHEBI:95060

subject_name: Dinaciclib


subject: CHEBI:95060

object_name: breast neoplasm


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:167450

object_name: myoclonic dystonia 11


subject: UMLS:C1382110

subject_name: powder physical state

object_name: Hemodynamic instability


subject: CHEBI:32599

object_name: Varicose veins of lower extremity


subject: CHEBI:32599

object_name: Hernia


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: opioid use


subject: UMLS:C5782829

object_name: Gender Dysphoria


subject: UMLS:C5782829

object_name: gender incongruence


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: nicotine dependence


subject: CHEBI:70714

subject_name: Teflaro

object_name: pneumonia


subject: CHEBI:70714

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:131674970

object_name: diverticulitis


subject: PUBCHEM.COMPOUND:131674970

object_name: peritonitis


subject: PUBCHEM.COMPOUND:131674970

object_name: cholecystitis


subject: PUBCHEM.COMPOUND:131674970

object_name: Cholecystitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:131674970

object_name: Cholecystitis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:131674970

object_name: appendicitis


subject: PUBCHEM.COMPOUND:131674970

object_name: Appendicitis, CTCAE


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:3514


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:32297

subject_name: Vinpocetine

object_name: Parkinson disease


subject: CHEBI:91571


subject: CHEBI:83766

subject_name: Olaparib

object_name: suppressor of tumorigenicity 3


subject: DRUGBANK:DB15546

subject_name: Skim milk

object_name: type 2 diabetes mellitus


subject: CHEBI:94782

subject_name: Cediranib

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:94782

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:94782

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:94782

object_name: metastatic melanoma


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UNII:68AYS9A614


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: CHEBI:90227

subject_name: Selumetinib


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Rotator Cuff Injuries


subject: CHEBI:3215

object_name: Rotator Cuff Injury, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650520

subject_name: LEMZOPARLIMAB

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL4650520

object_name: adult acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650520

object_name: childhood acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4650520

object_name: acute myeloid leukemia


subject: UMLS:C5235865


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Surgical procedure finding


subject: UMLS:C0360094

object_name: digestive system disorder


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: Android obesity


subject: UMLS:C0037668

object_name: Abdominal obesity


subject: UNII:4UR7N9Z9MM

subject_name: Somatorelin


subject: UNII:4UR7N9Z9MM


subject: GTOPDB:3602

subject_name: GHRH


subject: GTOPDB:3602


subject: UNII:Q5I7SFZ853

subject_name: Pegsunercept

object_name: rheumatoid arthritis


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: dehydration (Na, H2O)


subject: CHEBI:26710

object_name: Dehydration, CTCAE


subject: CHEBI:26710

object_name: Dehydration


subject: CHEBI:26710

object_name: Advanced cancer


subject: CHEBI:30011

subject_name: L-glutamine residue

object_name: peripheral nervous system disorder


subject: CHEBI:30011

object_name: neuropathy


subject: CHEBI:80270

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:80270

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C3274627

subject_name: Synbiotic Supplement

object_name: Nutritional status


subject: UMLS:C1174050

subject_name: cardiomyopeptidin

object_name: Left Ventricular Ejection Fraction


subject: CHEBI:63634

subject_name: Valdecoxib


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: diabetic neuropathy


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Childhood Breast Carcinoma


subject: CHEBI:3160

object_name: breast carcinoma


subject: CHEBI:3160

object_name: breast cancer


subject: CHEBI:3160

object_name: Post-Operative Pain


subject: CHEBI:3160

object_name: breast disorder


subject: CHEBI:3160

object_name: BRCA1 gene mutation


subject: CHEBI:3160

object_name: BRCA2 gene mutation


subject: CHEBI:3160

object_name: neoplasm


subject: UMLS:C4724944

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4724944

object_name: non-small cell lung carcinoma


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:84500


subject: CHEBI:194135

subject_name: Ofloxacin

object_name: periodontitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UMLS:C1289919

subject_name: Intravenous fluid

object_name: Sepsis


subject: UMLS:C1289919

object_name: Sepsis, CTCAE


subject: UMLS:C1289919

object_name: Severe Sepsis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: digestive system disorder


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: liver disorder


subject: CHEBI:8228


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Nutritional status


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: HMDB:HMDB0256702

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: HMDB:HMDB0256702

object_name: Metastatic non-small cell lung cancer


subject: HMDB:HMDB0256702

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:IC9O2HT1X1

object_name: Stomach cancer


subject: UNII:IC9O2HT1X1

object_name: gastric cancer


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Postoperative Complications


subject: CHEBI:7852

object_name: Postoperative Pain, Chronic


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: UMLS:C4727560


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:5466794

object_name: DS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5466794

object_name: ISS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5466794

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5466794

object_name: ISS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5466794

object_name: ISS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5466794

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:47344


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Feeding disorder neonatal


subject: MESH:D000077325

object_name: intestinal disorder


subject: UMLS:C2239199

subject_name: Digestive Surfactants

object_name: congenital alveolar dysplasia


subject: UMLS:C2239199

object_name: respiratory distress syndrome in premature infants


subject: UMLS:C2239199

object_name: adult acute respiratory distress syndrome


subject: UMLS:C2239199

object_name: newborn respiratory distress syndrome


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: multiple sclerosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Chronic intractable migraine without aura


subject: CHEBI:41879

object_name: migraine with aura


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:192842

subject_name: Methoxyamine

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:192842

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:192842

object_name: lung large cell carcinoma


subject: CHEBI:192842

object_name: lung adenocarcinoma


subject: CHEBI:8884

subject_name: Rocuronium

object_name: respiratory system disorder


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:78825

subject_name: Avutometinib

object_name: neoplasm


subject: UMLS:C2703210


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Human Papilloma Virus, Female


subject: CHEBI:35176

object_name: Human Papilloma Virus, Male


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: chalazion


subject: PUBCHEM.COMPOUND:22227703

object_name: hordeolum externum


subject: PUBCHEM.COMPOUND:22227703

object_name: hordeolum


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:50848


subject: CHEBI:50848


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C0591457

subject_name: Erwinase


subject: CHEBI:131174

subject_name: Navitoclax


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: CHEBI:41879

object_name: malnutrition


subject: CHEBI:41879

object_name: cancer-related condition


subject: CHEBI:66964

subject_name: Dronabinol

object_name: lung cancer


subject: CHEBI:66964

object_name: lung neoplasm


subject: CHEBI:66964

object_name: lung carcinoma


subject: CHEBI:66964

object_name: exocrine pancreatic carcinoma


subject: CHEBI:66964

object_name: malignant pancreatic neoplasm


subject: CHEBI:66964

object_name: outcomes general quality of life


subject: CHEBI:66964

object_name: Perceived quality of life


subject: CHEBI:66964

object_name: Good quality of life


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964

object_name: Neck Carcinoma


subject: CHEBI:66964

object_name: head and neck neoplasm


subject: CHEBI:66964

object_name: head and neck cancer


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950

object_name: pancreatic neoplasm


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6801

subject_name: Metformin

object_name: Premature pubarche


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Plexosarcoma


subject: CHEBI:230905

object_name: colorectal cancer


subject: CHEBI:230905

object_name: colorectal carcinoma


subject: CHEBI:230905

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:230905

object_name: esophageal squamous cell carcinoma


subject: GTOPDB:10140

subject_name: spartalizumab


subject: GTOPDB:10140


subject: GTOPDB:10140


subject: GTOPDB:10140


subject: GTOPDB:10140


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155


subject: UMLS:C4528574

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: CHEBI:90620

subject_name: Vatalanib

object_name: childhood neoplasm


subject: CHEBI:90620

object_name: neoplastic syndrome


subject: CHEBI:90620

object_name: cancer or benign tumor


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: CHEBI:95118

subject_name: Diclazuril

object_name: cryptosporidiosis


subject: CHEBI:95118

object_name: HIV infection


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4086713

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:50369

subject_name: Chromium picolinate

object_name: benign prostatic hyperplasia


subject: CHEBI:136034

subject_name: Afamelanotide

object_name: acne


subject: UMLS:C0066889

subject_name: MT-I


subject: UMLS:C2826131

object_name: leukemia


subject: UMLS:C2826131

object_name: childhood leukemia


subject: UMLS:C2826131

object_name: adult lymphoma


subject: UMLS:C2826131

object_name: lymphoma


subject: UMLS:C2826131

object_name: pediatric lymphoma


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: crescentic glomerulonephritis


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Post-COVID-19 syndrome


subject: CHEBI:76016

object_name: long COVID-19


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Parkinson disease


subject: CHEBI:229661

subject_name: Omaveloxolone

object_name: melanoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:4026

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:4026

object_name: adrenal gland pheochromocytoma


subject: CHEBI:4026

object_name: pheochromocytoma


subject: CHEBI:4026

object_name: paraganglioma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:3368

object_name: acral lentiginous melanoma


subject: PUBCHEM.COMPOUND:3368

object_name: Acral Melanoma


subject: PUBCHEM.COMPOUND:3368

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:3368

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:3368

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:3368

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:3368

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: adrenal carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: adrenal cortex carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: adrenal gland pheochromocytoma


subject: PUBCHEM.COMPOUND:3368

object_name: pheochromocytoma


subject: PUBCHEM.COMPOUND:3368

object_name: paraganglioma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:63599

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C1434005

object_name: Parkinson disease


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: otitis media


subject: CHEBI:2676

object_name: Otitis Media, CTCAE


subject: CHEBI:3347

subject_name: Candesartan

object_name: cluster headache syndrome


subject: MESH:C079420

subject_name: Lorenzo's oil

object_name: adrenomyeloneuropathy


subject: MESH:C079420

object_name: adrenoleukodystrophy


subject: MESH:C079420

object_name: X-linked cerebral adrenoleukodystrophy


subject: CHEBI:64816

object_name: inflammatory breast carcinoma


subject: CHEBI:64816

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:64816

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:64816

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:6A901E312A


subject: UMLS:C0719043

subject_name: Bupivacaine Hydrochloride-Epinephrine

object_name: thyroid tumor


subject: UMLS:C0719043

object_name: parathyroid gland adenoma


subject: UMLS:C0359949

subject_name: epinephrine / lidocaine


subject: UMLS:C0359949


subject: PUBCHEM.COMPOUND:2269

object_name: Asthma attack


subject: PUBCHEM.COMPOUND:2269

object_name: Acute asthma


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Burn injury


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Androgen excess


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Overweight


subject: PUBCHEM.COMPOUND:3062

object_name: obesity


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:32139


subject: CHEBI:32139


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:43805

object_name: Adult Giant Cell Glioblastoma


subject: PUBCHEM.COMPOUND:43805

object_name: Adult Gliosarcoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:91951

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UNII:C88817F47Y

object_name: Disseminated Malignant Neoplasm


subject: UNII:C88817F47Y

object_name: Embolism, Tumor


subject: UNII:C88817F47Y

object_name: Advanced cancer


subject: UNII:C88817F47Y

object_name: Carcinoma breast stage IV


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y

object_name: non-small cell lung carcinoma


subject: UNII:C88817F47Y

object_name: non-Hodgkin lymphoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: granulomatosis with polyangiitis


subject: UMLS:C0281549

subject_name: Zenapax


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: mandibular cancer


subject: CHEBI:73788

subject_name: Ala-Gln


subject: UMLS:C0594563

subject_name: Dipeptiven


subject: CHEBI:23965

subject_name: estradiol

object_name: Menopausal syndrome


subject: CHEBI:17026

subject_name: Progesterone

object_name: Childhood Breast Carcinoma


subject: CHEBI:17026

object_name: breast carcinoma


subject: CHEBI:17026

object_name: breast cancer


subject: CHEBI:17026

object_name: osteoporosis


subject: CHEBI:17026

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:17026

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:17026

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C2757070


subject: UMLS:C5787192

subject_name: LAM 561

object_name: Brain Stem Glioblastoma


subject: UMLS:C5787192

object_name: glioma susceptibility 1


subject: UMLS:C5787192

object_name: IDH-wildtype glioblastoma


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Hip Injuries


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Albuminuria


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: Infertility and Sterility, CTCAE


subject: CHEBI:59224

subject_name: Cetrorelix


subject: UMLS:C0872997

subject_name: SB 075 Acetate


subject: CHEBI:135910

subject_name: Ganirelix


subject: UMLS:C0872894

subject_name: ganirelix acetate


subject: UMLS:C5227659

object_name: Alstrom syndrome


subject: CHEBI:36791

subject_name: Escitalopram

object_name: pulmonary hypertension


subject: CHEBI:36791

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:3367

object_name: Ovarian cancer stage IV


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: benign neoplasm of hypopharynx


subject: UMLS:C3641122


subject: UMLS:C2347570

object_name: breast neoplasm


subject: CHEBI:7575

subject_name: Nimodipine

object_name: reversible cerebral vasoconstriction syndrome


subject: CHEBI:147155

object_name: Weight loss


subject: CHEBI:147155

object_name: Weight Loss, CTCAE


subject: CHEBI:62263


subject: CHEBI:62263


subject: UMLS:C1506837

object_name: Her2-receptor negative breast cancer


subject: UMLS:C1506837

object_name: triple-negative breast carcinoma


subject: UMLS:C1506837

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Disorder of transplanted kidney


subject: CHEBI:7915

subject_name: Pantoprazole


subject: PUBCHEM.COMPOUND:75038

object_name: Arterial calcification


subject: PUBCHEM.COMPOUND:75038

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: HBV coinfection


subject: CHEBI:59902

object_name: Klatskin Tumor


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717

object_name: liver carcinoma


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Intraoperative Hemorrhage


subject: CHEBI:59204

object_name: Intrapartum hemorrhage


subject: DRUGBANK:DB17523

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB17523

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB17523

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17523

object_name: Solid Neoplasm


subject: DRUGBANK:DB17523

object_name: nonpapillary renal cell carcinoma


subject: DRUGBANK:DB17523

object_name: clear cell renal carcinoma


subject: DRUGBANK:DB17523

object_name: renal cell adenocarcinoma


subject: DRUGBANK:DB17523

object_name: renal cell carcinoma


subject: DRUGBANK:DB17523

object_name: neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Cancer Other


subject: PUBCHEM.COMPOUND:156195543

subject_name: REZATAPOPT

object_name: Locally Advanced Malignant Neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:156195543

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:156195543

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:156195543


subject: PUBCHEM.COMPOUND:156195543

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:156195543

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:156195543

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: breast cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: lung cancer


subject: PUBCHEM.COMPOUND:156195543

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:156195543

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:156195543

object_name: small cell carcinoma


subject: DRUGBANK:DB18980

subject_name: Rezatapopt

object_name: Locally Advanced Malignant Neoplasm


subject: DRUGBANK:DB18980

object_name: Metastatic Malignant Solid Neoplasm


subject: DRUGBANK:DB18980

object_name: Advanced Malignant Solid Neoplasm


subject: DRUGBANK:DB18980

object_name: Disseminated Malignant Neoplasm


subject: DRUGBANK:DB18980

object_name: Embolism, Tumor


subject: DRUGBANK:DB18980

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB18980

object_name: Advanced cancer


subject: DRUGBANK:DB18980

object_name: Cancer Other


subject: DRUGBANK:DB18980

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB18980

object_name: Triple-Negative Breast Cancer Finding


subject: DRUGBANK:DB18980

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB18980

object_name: Neck Carcinoma


subject: DRUGBANK:DB18980

object_name: head and neck neoplasm


subject: DRUGBANK:DB18980

object_name: head and neck cancer


subject: DRUGBANK:DB18980

object_name: small cell lung carcinoma


subject: DRUGBANK:DB18980

object_name: prostate carcinoma


subject: DRUGBANK:DB18980

object_name: prostate cancer


subject: DRUGBANK:DB18980

object_name: Her2-receptor negative breast cancer


subject: DRUGBANK:DB18980

object_name: HER2 positive breast carcinoma


subject: DRUGBANK:DB18980

object_name: gallbladder cancer


subject: DRUGBANK:DB18980

object_name: endometrial cancer


subject: DRUGBANK:DB18980

object_name: uterine corpus cancer


subject: DRUGBANK:DB18980

object_name: endometrial carcinoma


subject: DRUGBANK:DB18980

object_name: colorectal cancer


subject: DRUGBANK:DB18980

object_name: colorectal carcinoma


subject: DRUGBANK:DB18980

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB18980

object_name: ovarian cancer


subject: DRUGBANK:DB18980

object_name: ovarian neoplasm


subject: DRUGBANK:DB18980

object_name: ovarian carcinoma


subject: DRUGBANK:DB18980

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB18980

object_name: breast carcinoma


subject: DRUGBANK:DB18980

object_name: breast cancer


subject: DRUGBANK:DB18980

object_name: lung cancer


subject: DRUGBANK:DB18980

object_name: lung neoplasm


subject: DRUGBANK:DB18980

object_name: lung carcinoma


subject: DRUGBANK:DB18980

object_name: small cell carcinoma


subject: UMLS:C3273311

subject_name: Gynoflor

object_name: Vaginal Atrophy


subject: DRUGBANK:DB17487


subject: DRUGBANK:DB17487


subject: DRUGBANK:DB17487


subject: DRUGBANK:DB17487

object_name: non-small cell lung carcinoma


subject: UMLS:C5418049

subject_name: KRAS G12C Inhibitor GDC-6036


subject: UMLS:C5418049


subject: UMLS:C5418049


subject: UMLS:C5418049


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib


subject: UNII:L4C1UY2NYH


subject: UNII:L4C1UY2NYH


subject: UNII:L4C1UY2NYH


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Increased reactive oxygen species production


subject: CHEBI:63631

subject_name: Topiramate

object_name: social phobia


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:5466794

object_name: endometrial carcinoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: CHEBI:31596

subject_name: Febuxostat

object_name: Hyperuricosuria


subject: CHEBI:31596

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:31596

object_name: nephrolithiasis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C3179527

subject_name: AMG 761

object_name: asthma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:25681

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:25681

object_name: morbid obesity


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: grade III glioma


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:36704

subject_name: Imiquimod

object_name: breast neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: ERBB2 Gene Mutation


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Agitation states as acute reaction to gross stress


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:194548

subject_name: Racepinephrine


subject: UMLS:C5203268

subject_name: Pegaptanib Sodium Injection

object_name: macular degeneration


subject: UMLS:C5203268

object_name: retinitis pigmentosa 30


subject: UMLS:C1621008

subject_name: INJECTION, PEGAPTANIB SODIUM, 0.3 MG Administered


subject: UMLS:C1621008


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Platinum-Refractory Ovarian Carcinoma


subject: CHEBI:28748

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: CHEBI:28748

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:28748

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Non-viable pregnancy


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:71025

object_name: Blighted ovum


subject: CHEBI:71025

object_name: Missed abortion


subject: UMLS:C2366367

subject_name: Cinryze

object_name: Delayed Graft Function


subject: UMLS:C2366367

object_name: Ischemic reperfusion injury


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor


subject: UMLS:C0540301


subject: UMLS:C0540301

object_name: kidney failure


subject: UMLS:C0540301

object_name: end stage renal failure


subject: UMLS:C0540301

object_name: Chronic uremia


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: PR:000014707

subject_name: plasma protease C1 inhibitor


subject: PR:000014707


subject: PR:000014707


subject: PR:000014707


subject: PR:000014707


subject: UMLS:C5417781


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Systemic Vasculitis


subject: UNII:4F4X42SYQ6

object_name: necrotizing vasculitis


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:MQ908Y1ZB2

object_name: neuralgia


subject: UNII:MQ908Y1ZB2

object_name: Neuropathic pain


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Adult Penile Carcinoma


subject: CHEBI:31355

object_name: penis carcinoma


subject: CHEBI:31355

object_name: penile cancer


subject: CHEBI:31355

object_name: squamous cell carcinoma of penis


subject: CHEBI:31355

object_name: Locally Advanced Penile Carcinoma


subject: CHEBI:31355

object_name: Male Urogenital Diseases


subject: CHEBI:31355

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: GTOPDB:12990

subject_name: sintilimab

object_name: oral cavity carcinoma


subject: GTOPDB:12990

object_name: oral cavity cancer


subject: GTOPDB:12990

object_name: precancerous condition


subject: GTOPDB:12990

object_name: mouth neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C2934873

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:56842157

subject_name: CHOP regimen

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4733669

subject_name: Monoclonal Microbial EDP1503

object_name: metastatic colorectal cancer


subject: UMLS:C4733669

object_name: triple-negative breast carcinoma


subject: UMLS:C4733669

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4733669

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4733669

object_name: clear cell renal carcinoma


subject: UMLS:C4733669

object_name: renal cell adenocarcinoma


subject: UMLS:C4733669

object_name: renal cell carcinoma


subject: UMLS:C4733669

object_name: bladder tumor


subject: UMLS:C4733669

object_name: urinary bladder carcinoma


subject: UMLS:C4733669

object_name: urinary bladder cancer


subject: UMLS:C4733669

object_name: childhood bladder carcinoma


subject: UMLS:C4733669

object_name: gastroesophageal cancer


subject: UMLS:C4733669

object_name: non-small cell lung carcinoma


subject: UMLS:C4733669


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: Cerebral Arteriosclerosis


subject: CHEBI:35457

object_name: arteriosclerosis disorder


subject: CHEBI:35457

object_name: atherosclerosis


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: cardiovascular disorder


subject: UMLS:C0085826

object_name: heart disorder


subject: UMLS:C0085826


subject: UMLS:C0085826

object_name: hypertension


subject: UMLS:C0085826

object_name: Hypertension, CTCAE


subject: UMLS:C0085826

object_name: diabetes mellitus


subject: UMLS:C0085826


subject: UMLS:C0085826


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: CHEBI:32316

subject_name: Zotepine

object_name: schizophrenia


subject: CHEBI:45652

subject_name: Succinylcholine

object_name: Depressed mood


subject: CHEBI:45652

object_name: Cancer patients and suicide and depression


subject: CHEBI:45652

object_name: Depressed - symptom


subject: CHEBI:45652

object_name: Depression, CTCAE


subject: UMLS:C0872997

subject_name: SB 075 Acetate

object_name: Encounter due to In vitro fertilization


subject: UMLS:C0872997

object_name: infertility


subject: CHEBI:32058

subject_name: Proglumide

object_name: Pancreatic fibrosis


subject: CHEBI:32058

object_name: Safety Issues


subject: CHEBI:7459

subject_name: Naloxone

object_name: epilepsy


subject: CHEBI:84040

object_name: common cold


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UNII:55E08EN074


subject: UNII:55E08EN074

object_name: Postoperative Complications


subject: CHEBI:9329

subject_name: Sulfadoxine

object_name: anemia


subject: CHEBI:9329

object_name: Anemia, CTCAE


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:8673


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:54214995

object_name: Acute heart failure


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: PUBCHEM.COMPOUND:71300864


subject: PUBCHEM.COMPOUND:71300864


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C2933615


subject: CHEBI:6532

subject_name: Loperamide

object_name: short bowel syndrome


subject: CHEBI:6532

object_name: ulcerative colitis


subject: CHEBI:6532

object_name: inflammatory bowel disease 1


subject: CHEBI:6532

object_name: rectal carcinoma


subject: CHEBI:6532

object_name: rectal cancer


subject: CHEBI:6532

object_name: Childhood Rectal Carcinoma


subject: PUBCHEM.COMPOUND:40703

subject_name: PINAVERIUM BROMIDE

object_name: bile duct disorder


subject: UNII:7SCF54H12J

subject_name: Pinaverium bromide [MI]


subject: CHEBI:135811

subject_name: Pinaverium


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: PUBCHEM.COMPOUND:5466794

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: recurrent cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:5466794

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:5466794

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:47344

subject_name: Alvocidib

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:47344

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:47344

object_name: anaplastic large cell lymphoma


subject: CHEBI:47344

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:47344

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:47344

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:47344

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:47344

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:47344

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:47344

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:47344

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:47344

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:47344

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:47344

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:47344

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:47344

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:47344

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:47344

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:156963690

subject_name: Somapacitan

object_name: Noonan syndrome


subject: PUBCHEM.COMPOUND:156963690

object_name: Noonan syndrome 1


subject: PUBCHEM.COMPOUND:156963690

object_name: Turner syndrome


subject: PUBCHEM.COMPOUND:156963690

object_name: SHOX-related short stature


subject: CHEBI:50730

subject_name: Montelukast

object_name: Well adult


subject: CHEBI:49165


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: metastatic prostate carcinoma


subject: CHEBI:22652

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:22652

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:22652

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:22652

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:22652

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Allergy to etamsylate


subject: CHEBI:59204

object_name: Allergy to misoprostol


subject: CHEBI:59204

object_name: Allergy to oxytocin


subject: CHEBI:59204

object_name: Allergy to tranexamic acid


subject: CHEBI:63610

subject_name: Misoprostol

object_name: myoma


subject: CHEBI:63610


subject: CHEBI:63610


subject: CHEBI:63610


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: CHEBI:31563

subject_name: Etamsylate


subject: CHEBI:31563


subject: CHEBI:31563


subject: CHEBI:31563


subject: CHEBI:31563


subject: CHEBI:15379

subject_name: Oxygen

object_name: Fetal distress


subject: CHEBI:15379

object_name: perinatal asphyxia


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Solid Neoplasm


subject: UMLS:C2934122


subject: UMLS:C4053677


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Growth & development aspects


subject: CHEBI:35176

object_name: osteoporosis


subject: CHEBI:35176

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:35176

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:35176

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: EXCESS LMW-DNA


subject: UNII:3S252O2Z4X

object_name: Still Disease


subject: UNII:3S252O2Z4X

object_name: Still's disease with juvenile onset and/or adult onset


subject: UNII:3S252O2Z4X

object_name: meconium aspiration syndrome


subject: UNII:3S252O2Z4X

object_name: McCune-Albright syndrome


subject: UNII:3S252O2Z4X


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: prostate cancer


subject: CHEBI:81579

object_name: prostate neoplasm


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C1446777

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1446777

object_name: acute leukemia


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: ADHF


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Lung squamous cell carcinoma recurrent


subject: CHEBI:231679

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: coronary microvascular disorder


subject: CHEBI:63598

subject_name: Levofloxacin

object_name: rifampicin-resistant tuberculosis


subject: CHEBI:63598

object_name: extensively drug-resistant tuberculosis


subject: CHEBI:63598


subject: CHEBI:63607

subject_name: Linezolid


subject: UNII:D959AE5USF

subject_name: clofazimine


subject: UNII:D959AE5USF


subject: CHEBI:6909

subject_name: Metronidazole

object_name: digestive system disorder


subject: CHEBI:6909

object_name: Adverse effects


subject: DRUGBANK:DB19013

subject_name: Insulin efsitora alfa

object_name: Melanoma of the Ciliary Body and Choroid pT2d TNM Finding v7


subject: DRUGBANK:DB19013

object_name: T2d TNM Finding


subject: CHEBI:51097

subject_name: benzyloxycarbonyl group

object_name: HIV infection


subject: CHEBI:3057

subject_name: Benzyl formate


subject: CHEBI:3387

subject_name: Carbamazepine


subject: UMLS:C5785423

subject_name: RNA Transcription Modulator AU-409

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C5785423

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5785423

object_name: Advanced Cholangiocarcinoma


subject: UMLS:C5785423

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C5785423

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5785423

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Childhood Breast Carcinoma


subject: CHEBI:131701

object_name: breast carcinoma


subject: CHEBI:131701

object_name: breast cancer


subject: UNII:1SBRUI0C8R

subject_name: TISSUE-TYPE PLASMINOGEN ACTIVATOR

object_name: stroke disorder


subject: UNII:1SBRUI0C8R

object_name: cerebrovascular disorder


subject: UNII:1SBRUI0C8R

object_name: Stroke (heart beat)


subject: UNII:1SBRUI0C8R

object_name: Stroke, CTCAE


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Headache


subject: CHEBI:9667

object_name: Headache, CTCAE


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: Inflammatory abnormality of the eye


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:63115

object_name: Tingling


subject: CHEBI:63115

object_name: Paresthesia


subject: CHEBI:63115

object_name: Hypoesthesia


subject: CHEBI:63115

object_name: Numbness


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: primary progressive multiple sclerosis


subject: UMLS:C0665297

subject_name: natalizumab


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Adult bronchiectasis


subject: UMLS:C3257792

subject_name: Bydureon

object_name: chronic kidney disease


subject: UMLS:C3257792

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3257792

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: UMLS:C3257792

object_name: Left ventricular diastolic dysfunction


subject: CHEBI:64073


subject: CHEBI:64073


subject: CHEBI:64073


subject: CHEBI:64073


subject: UMLS:C5555821

subject_name: mRNA-encoded Anti-Claudin18.2 Monoclonal Antibody BNT141

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555821

object_name: Adult Solid Neoplasm


subject: UMLS:C5555821

object_name: Solid Neoplasm


subject: UMLS:C5555821

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5555821

object_name: Embolism, Tumor


subject: UMLS:C5555821

object_name: Neoplasm Metastasis


subject: UMLS:C5555821

object_name: pancreatic neoplasm


subject: UMLS:C5555821

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5555821

object_name: malignant pancreatic neoplasm


subject: UMLS:C5555821

object_name: biliary tract cancer


subject: UMLS:C5555821

object_name: Stomach cancer


subject: UMLS:C5555821

object_name: gastric cancer


subject: UMLS:C5555821


subject: UMLS:C5555821

object_name: esophageal adenocarcinoma


subject: UMLS:C5555821

object_name: cholangiocarcinoma


subject: UMLS:C5555821

object_name: liver carcinoma


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: Pelvis fracture


subject: UMLS:C2348756

object_name: Hip Fracture, CTCAE


subject: UMLS:C2348756

object_name: hip fracture


subject: UMLS:C2348756

object_name: Paresis


subject: UMLS:C2348756

object_name: Muscle weakness


subject: CHEBI:32599

object_name: post pulmonary resection


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: oral submucous fibrosis


subject: CHEBI:31263

subject_name: Bentiromide


subject: PR:000005376

subject_name: complement factor D


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Mycoses


subject: UNII:13ZT6YG5SD

subject_name: methamphetamine

object_name: Harmful pattern of substance use


subject: UNII:13ZT6YG5SD

object_name: substance abuse


subject: CHEBI:6809

subject_name: Metamfetamine


subject: CHEBI:6809


subject: DRUGBANK:DB17528

object_name: non-small cell lung carcinoma


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C4722124


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UMLS:C2346876

subject_name: Aurora Kinase Inhibitor BI 811283

object_name: neoplasm


subject: UMLS:C2986391

subject_name: Anti-CD20 Monoclonal Antibody TL011

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5417942

object_name: arteriosclerosis disorder


subject: UMLS:C5417942

object_name: atherosclerosis


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Fractured ankle


subject: UMLS:C4086546

object_name: Ankle Fracture, CTCAE


subject: CHEBI:232390

object_name: recurrent acute pancreatitis


subject: CHEBI:195285

object_name: osteoarthritis


subject: CHEBI:195285

object_name: osteoarthritis susceptibility 1


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: panic disorder


subject: PUBCHEM.COMPOUND:57505028

object_name: panic disorder 1


subject: UNII:4G4Z4676IS

subject_name: buciclovir

object_name: cytomegalovirus infection


subject: UNII:4G4Z4676IS

object_name: adenoviridae infectious disease


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: high-risk pregnancy


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909

object_name: preterm premature rupture of the membranes


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: hypertension chronic


subject: CHEBI:3654

object_name: kidney failure


subject: UMLS:C1739076

object_name: melanoma


subject: CHEBI:50847

subject_name: immunological adjuvant


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: rheumatic heart disease


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: Control of hip fracture risk


subject: CHEBI:36088

object_name: hip fracture


subject: CHEBI:36088

object_name: Intertrochanteric Fractures


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: Long Term Adverse Effects


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: UMLS:C5814356

object_name: paroxysmal nocturnal hemoglobinuria


subject: UniProtKB:Q05920

subject_name: PYC_MOUSE Pyruvate carboxylase, mitochondrial (sprot)

object_name: hypoplastic left heart syndrome


subject: UniProtKB:Q05920

object_name: familial atrioventricular septal defect


subject: CHEMBL.COMPOUND:CHEMBL3545318

subject_name: REXLEMESTROCEL-L


subject: CHEMBL.COMPOUND:CHEMBL3545318


subject: CHEBI:47657

subject_name: Roflumilast

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:2367

subject_name: Betnesol

object_name: Central Nervous System Sensitization


subject: PUBCHEM.COMPOUND:2367

object_name: shoulder impingement syndrome


subject: PUBCHEM.COMPOUND:2367

object_name: Coracohumeral Impingement Syndrome


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: UMLS:C0244231

subject_name: Diprospan


subject: UMLS:C0244231


subject: UMLS:C0244231


subject: UNII:74T7185BMM

subject_name: Inebilizumab

object_name: myasthenia gravis


subject: UNII:74T7185BMM

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C2981806


subject: UMLS:C2981806


subject: CHEBI:6801

subject_name: Metformin

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: Recurrent Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: adult hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: Vascular endothelial growth factor overexpression


subject: PUBCHEM.COMPOUND:104747

object_name: Adverse drug response


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: reproductive disorder


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: digestive system neoplasm


subject: UNII:M89N0Q7EQR

object_name: Neoplasm of the gastrointestinal tract


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379

object_name: gallbladder cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: digestive system cancer


subject: PR:000001151

object_name: colon carcinoma


subject: PR:000001151

object_name: colon cancer


subject: PR:000001151


subject: UNII:2CQ8Y0B8XQ

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: prostate cancer


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: temporal arteritis


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Hypotension during surgery


subject: UMLS:C0796325

subject_name: Carmustine Implant

object_name: glioblastoma


subject: UMLS:C0796325

object_name: Brain Stem Glioblastoma


subject: UMLS:C0796325

object_name: glioma susceptibility 1


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Disseminated Malignant Neoplasm


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:75551

object_name: cancer pain


subject: CHEBI:94463

object_name: Hantavirosis


subject: CHEBI:94463

object_name: hantavirus hemorrhagic fever with renal syndrome


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Pentoxifylline adverse reaction


subject: CHEBI:7986

object_name: Neonatal encephalopathy


subject: CHEBI:7986

object_name: perinatal asphyxia


subject: CHEBI:7986

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:7986

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:7986

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: UMLS:C3273936

object_name: metastatic colorectal cancer


subject: CHEBI:78030


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:71219

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:71219

object_name: stage IA breast cancer


subject: CHEBI:71219

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:71219

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:71219

object_name: malignant neoplasm of breast stage IIb


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: ulcerative colitis


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:164200

subject_name: Triclosan

object_name: Periodontal Disease, CTCAE


subject: CHEBI:29228

subject_name: FLUORIDE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: UMLS:C5959684

subject_name: Anti-CEA/Anti-DR5 Bispecific Antibody IBI3004

object_name: Childhood Solid Neoplasm


subject: UMLS:C5959684

object_name: Adult Solid Neoplasm


subject: UMLS:C5959684

object_name: Solid Neoplasm


subject: GTOPDB:8265

subject_name: abagovomab

object_name: ovarian cancer


subject: GTOPDB:8265

object_name: ovarian neoplasm


subject: GTOPDB:8265

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1742981

subject_name: ABAGOVOMAB


subject: CHEMBL.COMPOUND:CHEMBL1742981


subject: CHEMBL.COMPOUND:CHEMBL1742981


subject: UMLS:C1832044


subject: UMLS:C1832044


subject: UMLS:C1832044


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: hereditary angioedema


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Disorder of wrist joint


subject: CHEBI:41879

object_name: familial Dupuytren contracture


subject: CHEBI:41879

object_name: palmar fibromatosis


subject: CHEBI:41879

object_name: finger fracture


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C4086546


subject: UMLS:C0487940

subject_name: Lb substance


subject: UMLS:C0487940


subject: UMLS:C0487940


subject: UMLS:C0487940

object_name: Distal Radius Fractures


subject: UMLS:C0487940


subject: PUBCHEM.COMPOUND:90877554

object_name: Cannabis use disorder


subject: UMLS:C2351846


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: DRUGBANK:DB14296

subject_name: Panax quinquefolius whole

object_name: hypertension


subject: DRUGBANK:DB14296

object_name: Hypertension, CTCAE


subject: UMLS:C3192374

subject_name: Nicotine Nasal Spray

object_name: Post-Operative Pain


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: pancreatic neoplasm


subject: UMLS:C0919079

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0919079

object_name: malignant pancreatic neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEMBL.COMPOUND:CHEMBL3990008

subject_name: TABELECLEUCEL

object_name: Childhood Leiomyosarcoma


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: Adult Leiomyosarcoma


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: vasomotor symptom


subject: UMLS:C0730772

subject_name: Livial


subject: CHEBI:76842

object_name: Surgical procedure finding


subject: CHEBI:76842

object_name: nervous system disorder


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C5417893

subject_name: TGF-beta Receptor 1 Kinase Inhibitor YL-13027

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417893

object_name: Adult Solid Neoplasm


subject: UMLS:C5417893

object_name: Solid Neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Physical trauma


subject: CHEBI:73604

object_name: Injury


subject: CHEBI:73604

object_name: Trauma


subject: CHEBI:73604

object_name: Traumatic Shock


subject: CHEBI:143825

subject_name: Ravuconazole

object_name: Infection


subject: CHEBI:143825

object_name: infectious disease


subject: CHEBI:143825

object_name: Adverse Event Associated with Infection


subject: CHEBI:143825

object_name: gestational trophoblastic neoplasm


subject: CHEBI:143825

object_name: testicular germ cell tumor 1


subject: CHEBI:143825

object_name: testicular germ cell tumor


subject: CHEBI:143825

object_name: childhood testicular germ cell tumor


subject: CHEBI:143825


subject: CHEBI:143825

object_name: myeloproliferative neoplasm


subject: CHEBI:143825

object_name: Myelodysplasia


subject: CHEBI:143825

object_name: ovarian cancer


subject: CHEBI:143825

object_name: ovarian neoplasm


subject: CHEBI:143825

object_name: ovarian carcinoma


subject: CHEBI:143825

object_name: Childhood Breast Carcinoma


subject: CHEBI:143825

object_name: breast carcinoma


subject: CHEBI:143825

object_name: breast cancer


subject: CHEBI:143825

object_name: Childhood Neuroblastoma


subject: CHEBI:143825

object_name: neuroblastoma


subject: CHEBI:143825

object_name: adult lymphoma


subject: CHEBI:143825

object_name: lymphoma


subject: CHEBI:143825

object_name: pediatric lymphoma


subject: CHEBI:143825

object_name: leukemia


subject: CHEBI:143825

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: UMLS:C5706511

subject_name: Anti-B7-H3 Antibody-drug Conjugate YL201

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: multiple sclerosis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C1831849

object_name: breast neoplasm


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: irritable bowel syndrome


subject: DRUGBANK:DB19248

object_name: superficial epidermolytic ichthyosis


subject: CHEBI:67271

object_name: mast cell leukemia


subject: CHEBI:67271

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:67271

object_name: aggressive NK-cell leukemia


subject: CHEBI:67271

object_name: prolymphocytic leukemia


subject: CHEBI:67271

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:67271

object_name: myeloid/NK-cell acute leukemia


subject: CHEBI:67271

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:67271

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:67271

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:67271

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:67271

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:67271

object_name: Blast Phase


subject: CHEBI:67271

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:67271

object_name: chronic eosinophilic leukemia


subject: CHEBI:67271

object_name: chronic neutrophilic leukemia


subject: CHEBI:67271

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:67271

object_name: acute undifferentiated leukemia


subject: CHEBI:67271

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:67271

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:67271

object_name: chronic myelomonocytic leukemia


subject: CHEBI:67271

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:67271

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:67271

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:67271

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:67271

object_name: acute myeloid leukemia/transient myeloproliferative disorder


subject: CHEBI:67271

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:67271

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:67271

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:67271

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:67271

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:67271

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:67271

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:67271

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:67271

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:67271

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:67271

object_name: primary central nervous system Hodgkin lymphoma


subject: CHEBI:67271


subject: CHEBI:67271

object_name: Burkitt lymphoma


subject: CHEBI:67271

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:168429725

subject_name: survodutide

object_name: Liver Fibrosis


subject: UNII:2ALA66NS64

subject_name: SURVODUTIDE


subject: CHEBI:59527

object_name: hypnic headache


subject: CHEBI:59527

object_name: Tension-type headache


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:10650

subject_name: Sumatriptan


subject: CHEBI:10650


subject: CHEBI:64755

object_name: Pulp and periapical tissue disease


subject: CHEBI:64755

object_name: granuloma; pulp


subject: CHEBI:64755

object_name: dental pulp necrosis


subject: CHEBI:4735

subject_name: Edetic acid


subject: CHEBI:4735


subject: CHEBI:4735


subject: CHEBI:157844

subject_name: Glu-Arg


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: CHEBI:157802

subject_name: Cys-Arg


subject: CHEBI:157802


subject: CHEBI:157802


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: CHEBI:49544


subject: PR:000004968

subject_name: calretinin


subject: PR:000004968


subject: PR:000004968


subject: PR:000006466

subject_name: dehydrogenase/reductase SDR family member 4


subject: PR:000006466


subject: PR:000006466


subject: PR:000025662

subject_name: complement decay-accelerating factor


subject: PR:000025662


subject: PR:000025662


subject: UniProtKB:Q8VHX2

subject_name: EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


subject: UniProtKB:Q8VHX2


subject: UniProtKB:Q8VHX2


subject: PR:000006889

subject_name: ectodysplasin-A receptor-associated adapter protein


subject: PR:000006889


subject: PR:000006889


subject: UMLS:C4053663

object_name: melanoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: bile duct carcinoma


subject: CHEBI:72317

object_name: bile duct cancer


subject: CHEBI:72317

object_name: cholangiocarcinoma


subject: CHEBI:72317

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:72317

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Carcinoma breast stage IV


subject: CHEBI:73272

object_name: Childhood Breast Carcinoma


subject: CHEBI:73272

object_name: breast carcinoma


subject: CHEBI:73272

object_name: breast cancer


subject: CHEBI:73272

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:73272

object_name: malignant neoplasm of breast stage IV


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Adult Gliosarcoma


subject: CHEBI:91368

object_name: gliosarcoma


subject: CHEBI:91368

object_name: Childhood Gliosarcoma


subject: CHEBI:91368

object_name: Brain Stem Glioblastoma


subject: CHEBI:91368

object_name: glioma susceptibility 1


subject: UMLS:C5669858

subject_name: Magnesium Chloride-based Lotion

object_name: adult lymphoma


subject: UMLS:C5669858

object_name: lymphoma


subject: UMLS:C5669858

object_name: pediatric lymphoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Forearm Injuries


subject: CHEBI:60802

object_name: radius fracture


subject: CHEBI:60802

object_name: Fractured ulna


subject: CHEBI:60802

object_name: Wrist Injuries


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466

object_name: Hand Injuries


subject: CHEBI:4466


subject: CHEBI:4466


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: asthma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Epigastric hernia


subject: UMLS:C5960195

subject_name: TEAD Inhibitor BGC515

object_name: Childhood Solid Neoplasm


subject: UMLS:C5960195

object_name: Adult Solid Neoplasm


subject: UMLS:C5960195

object_name: Solid Neoplasm


subject: UMLS:C5960195

object_name: Mesothelioma


subject: UMLS:C5960195

object_name: mesothelial neoplasm


subject: UMLS:C5960195

object_name: malignant mesothelioma


subject: UMLS:C0939788

subject_name: Zometa

object_name: Childhood Breast Carcinoma


subject: UMLS:C0939788

object_name: breast carcinoma


subject: UMLS:C0939788

object_name: breast cancer


subject: CHEBI:80566

subject_name: Palifosfamide

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:80566

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:80566

object_name: sarcoma


subject: CHEBI:80566

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:80566

object_name: soft tissue sarcoma


subject: UMLS:C2987344

subject_name: palifosfamide-tris


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: UMLS:C2987344


subject: PUBCHEM.COMPOUND:23582788

subject_name: Tegoprazan

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C5417948

subject_name: HPV Vaccine PRGN-2009

object_name: head and neck squamous cell carcinoma


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: pulmonary systemic sclerosis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:3566

subject_name: cetylpyridinium chloride monohydrate

object_name: Dental Plaque


subject: CHEBI:3566

object_name: periodontal disorder


subject: CHEBI:165822

subject_name: CpC


subject: CHEBI:165822


subject: PUBCHEM.COMPOUND:54675873


subject: PUBCHEM.COMPOUND:54675873


subject: UMLS:C5959582

subject_name: Chromosomal Passenger Complex


subject: UMLS:C5959582


subject: UNII:4HA45S22ZZ

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:67271


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Menopause present (finding)


subject: CHEBI:7936

object_name: Menopause


subject: PUBCHEM.COMPOUND:2269

object_name: acne


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Refractory Severe Aplastic Anemia


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Mantle cell lymphoma stage III


subject: UNII:M89N0Q7EQR

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:M89N0Q7EQR

object_name: Mantle cell lymphoma stage IV


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:M89N0Q7EQR

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:M89N0Q7EQR

object_name: Marginal zone lymphoma stage III


subject: UNII:M89N0Q7EQR

object_name: Marginal zone lymphoma stage IV


subject: UNII:M89N0Q7EQR

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Adult Burkitt Lymphoma


subject: PR:000001379

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: PR:000001379

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000001379

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000001379

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PR:000001379

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: PR:000001379

object_name: Stage III Adult Immunoblastic Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: PR:000001379

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PR:000001379

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: PR:000001379

object_name: Mantle cell lymphoma stage III


subject: PR:000001379

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PR:000001379

object_name: B-cell small lymphocytic lymphoma stage III


subject: PR:000001379

object_name: Mantle cell lymphoma stage IV


subject: PR:000001379

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PR:000001379

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: PR:000001379

object_name: B-cell small lymphocytic lymphoma stage IV


subject: PR:000001379

object_name: Marginal zone lymphoma stage III


subject: PR:000001379

object_name: Marginal zone lymphoma stage IV


subject: PR:000001379

object_name: Stage III Adult Burkitt Lymphoma


subject: PR:000001379

object_name: Recurrent Adult Burkitt Lymphoma


subject: PR:000001379

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:82677

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:82677

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:31652

subject_name: Gimeracil

object_name: colorectal cancer


subject: CHEBI:31652

object_name: colorectal carcinoma


subject: CHEBI:31652

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31652

object_name: Embolism, Tumor


subject: CHEBI:31652

object_name: Neoplasm Metastasis


subject: CHEBI:31652

object_name: Metastatic Lesion


subject: UMLS:C3852659

subject_name: Teysuno


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: UMLS:C3852659


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Agitation, CTCAE 3.0


subject: CHEBI:8802

object_name: Agitation


subject: CHEBI:8802

object_name: Agitation, CTCAE 5.0


subject: DRUGBANK:DB18496

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: asthma


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: abortion in second trimester


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:32250

subject_name: tramadol hydrochloride

object_name: Sprains and Strains


subject: CHEBI:75722

subject_name: Tramadol


subject: PUBCHEM.COMPOUND:134156377

subject_name: HYDROCODONE BITARTRATE


subject: CHEBI:5779

subject_name: Hydrocodone


subject: CHEBI:8378

subject_name: Prednisolone

object_name: kaposiform hemangioendothelioma


subject: CHEBI:8378

object_name: Kasabach-Merritt syndrome


subject: CHEBI:9168

subject_name: Sirolimus


subject: UMLS:C0021658

subject_name: Humulin N

object_name: Malignant cachexia


subject: UMLS:C2983753

object_name: prostate neoplasm


subject: UMLS:C2346815

object_name: malignant soft tissue neoplasm


subject: UMLS:C2346815

object_name: sarcoma


subject: PUBCHEM.COMPOUND:73995022

subject_name: Casein

object_name: Endotoxemia


subject: PUBCHEM.COMPOUND:73995022

object_name: Nutritional status


subject: DRUGBANK:DB10516


subject: DRUGBANK:DB10516


subject: UMLS:C0007332

subject_name: caseins


subject: UMLS:C0007332


subject: UMLS:C5852982

subject_name: Cyfendus

object_name: anthrax disease


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: lung adenocarcinoma


subject: CHEBI:85078

object_name: lung cancer


subject: CHEBI:85078

object_name: lung neoplasm


subject: CHEBI:85078

object_name: lung carcinoma


subject: CHEBI:85078

object_name: Stage IA2 Lung Cancer AJCC v8


subject: CHEBI:85078

object_name: Stage IA3 Lung Cancer AJCC v8


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: pancreatic neoplasm


subject: CHEBI:65415

object_name: malignant pancreatic neoplasm


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Absence Seizure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:4315

subject_name: Danazol

object_name: TELOMERE LENGTH, MEAN LEUKOCYTE


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: RENAL FAILURE CHRONIC REQUIRING HEMODIALYSIS


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Erectile dysfunction due to arterial insufficiency


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:21873174

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:21873174

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:21873174

object_name: castration-resistant prostate carcinoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: heavy drinking


subject: UMLS:C2958902

subject_name: Injection, telavancin, 10 mg administered

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Mutation Abnormality


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: malignant pleural mesothelioma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: UMLS:C4752059

subject_name: Benserazide only product

object_name: sickle cell disease


subject: UMLS:C4752059

object_name: beta thalassemia


subject: UMLS:C4752059

object_name: beta-thalassemia intermedia


subject: UMLS:C5447487

subject_name: Anti-CTLA-4 Monoclonal Antibody YH001

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447487

object_name: Adult Solid Neoplasm


subject: UMLS:C5447487

object_name: Solid Neoplasm


subject: UMLS:C5554971

subject_name: Anti-CD40 Agonist Antibody YH003


subject: UMLS:C5554971


subject: UMLS:C5554971


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: renal carcinoma


subject: UNII:6A901E312A

object_name: kidney neoplasm


subject: UNII:6A901E312A

object_name: kidney cancer


subject: UMLS:C4744993

object_name: neoplasm


subject: UMLS:C4744993

object_name: Tumor Mass


subject: CHEBI:80755

object_name: adult lymphoma


subject: CHEBI:80755

object_name: lymphoma


subject: CHEBI:80755

object_name: pediatric lymphoma


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: Fetal Death


subject: UMLS:C3641632

subject_name: Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine

object_name: stage IIIB melanoma


subject: UMLS:C3641632

object_name: stage IIIC melanoma


subject: UMLS:C3641632

object_name: Melanoma recurrent


subject: UNII:2PEX5N7DQ4

subject_name: Fevipiprant

object_name: kidney failure


subject: CHEBI:5383

subject_name: Glimepiride

object_name: cardiovascular disorder


subject: CHEBI:28680

subject_name: Cytarabine

object_name: Childhood Breast Carcinoma


subject: CHEBI:28680

object_name: breast carcinoma


subject: CHEBI:28680

object_name: breast cancer


subject: CHEBI:167574

subject_name: Semaglutide

object_name: glucose intolerance


subject: CHEBI:167574

object_name: Impaired glucose tolerance